Copy Number
The putative cancer-associated PDGs driven by SCNAs in each cancer type were identified by four criteria: 1) located in a peak region of a significantly recurrent focal SNCA locus estimated by the genomic identification of significant targets in cancer (GISTIC2) algorithm, (q≤0.25); 2) altered with high frequency and large amplitude (G-score ≥0.1); 3) mRNA reliably detected in at least 10% of tumor specimens in the given cancer type (90th percentile of FPKM value ≥1); and 4) mRNA significantly and positively correlated with copy numbers (Pearson P-value less than 0.001).
| Showing page 8 |
first page | previous page | next page | last page |
| Overall_Gscore | No. of Cancer Types | ||||
| HGNC Symbol | Ensembl Gene ID | Amplification | Deletion | Amplification | Deletion |
| SLC12A3 | ENSG00000070915 | 0.00 | 0.00 | 0 | 0 |
| MGAT4A | ENSG00000071073 | 0.00 | 0.00 | 0 | 0 |
| WDR1 | ENSG00000071127 | 0.00 | 0.00 | 0 | 0 |
| ING3 | ENSG00000071243 | 0.00 | 0.00 | 0 | 0 |
| VASH1 | ENSG00000071246 | 0.00 | 0.11 | 0 | 1 |
| TRIB2 | ENSG00000071575 | 0.00 | 0.15 | 0 | 1 |
| PRLH | ENSG00000071677 | 0.00 | 0.00 | 0 | 0 |
| SPP2 | ENSG00000072080 | 0.00 | 0.00 | 0 | 0 |
| PTPN18 | ENSG00000072135 | 0.00 | 0.00 | 0 | 0 |
| ASIC4 | ENSG00000072182 | 0.00 | 0.00 | 0 | 0 |
| SPEG | ENSG00000072195 | 0.00 | 0.19 | 0 | 1 |
| ALDH3A2 | ENSG00000072210 | 0.67 | 0.21 | 1 | 1 |
| TRPC5 | ENSG00000072315 | 0.00 | 0.00 | 0 | 0 |
| HSD17B10 | ENSG00000072506 | 0.29 | 0.00 | 1 | 0 |
| HMMR | ENSG00000072571 | 0.00 | 0.00 | 0 | 0 |
| FCGR2B | ENSG00000072694 | 0.00 | 0.00 | 0 | 0 |
| CYP2W1 | ENSG00000073067 | 0.15 | 0.40 | 1 | 1 |
| ADAM11 | ENSG00000073670 | 0.00 | 0.00 | 0 | 0 |
| DHRS9 | ENSG00000073737 | 0.00 | 0.00 | 0 | 0 |
| CD5L | ENSG00000073754 | 0.00 | 0.00 | 0 | 0 |
|
Showing page 8 |
first page | previous page | next page | last page |
Copyright © 2020 University of Pennsylvania. All Rights Reserved.